Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
6271 - 6280 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2022
  • 2017
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    2024
    Summary Details
    OPEN
    Title: Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    Author(s): Yuri L. Sosero, Sara Bandrés‐Ciga, Bart Ferwerda, Maria Teresa Periñan Tocino, Dìaz R. Belloso, Pilar Gómez-Gil, Johann Faouzi, Pille Taba, Lukas Pavelka, Tainá M. Marques, Clarissa P. C. Gomes, Alexey Kolodkin, Patrick May, Łukasz Milanowski, Zbigniew K. Wszołek, Ryan J. Uitti, Peter Heutink, Jacobus J. van Hilten, David K. Simon, Shirley Eberly, Ignacio Álvarez, Lynne Krohn, Eric Yu, Kathryn Freeman, Uladzislau Rudakou, Jennifer A. Ruskey, Farnaz Asayesh, Manuel Menéndez‐González, Pau Pástor, Owen A. Ross, Rejko Krüger, Jean‐Christophe Corvol, Sulev Kõks, Pablo Mir, Rob M.A. de Bie, Hirotaka Iwaki, Ziv Gan‐Or
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 39
    Issue #: 10
    Start Page: 1773
    End Page: 1783
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29960
    Best OA location URL: https://doi.org/10.1002/mds.29960
    Citation Count: 3
  • Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine
    2024
    Summary Details
    OPEN
    Title: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine
    Author(s): Beatrice Zarrilli, Cecilia Giacomet, Francesca Cossa, Mauro Federici, Nicola Berretta, Nicola Biagio Mercuri
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 128
    Issue #:
    Start Page: 107158
    End Page: 107158
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158
    Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01170-2/pdf
    Citation Count: 2
  • The many genomes of Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: The many genomes of Parkinson's disease
    Author(s): Haydeh Payami
    Journal Name: International Review of Neurobiology
    Publisher: Elsevier
    Vol:
    Issue #:
    Start Page: 59
    End Page: 80
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/bs.irn.2022.07.007
    Citation Count: 3
  • Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
    2017
    Summary Details
    OPEN
    Title: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
    Author(s): Simone Bido, Federico N. Soria, Rebecca Z. Fan, Erwan Bézard, Kim Tieu
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Vol: 7
    Issue #: 1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-017-07181-0
    Best OA location URL: https://www.nature.com/articles/s41598-017-07181-0.pdf
    Citation Count: 115
  • Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study
    2022
    Summary Details
    OPEN
    Title: Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study
    Author(s): Cloé Domenighetti, Pierre‐Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Océane Mohamed, Berta Portugal, Patrick May, Dheeraj Reddy Bobbili, Milena Radivojkov‐Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Kõks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean‐Christophe Corvol, Marie‐Christine Chartier‐Harlin, Eugénie Mutez, Kathrin Brockmann, Angela Deutschländer, G. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Yusuke Kawamura, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P.C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrøm, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pástor, Mónica Díez-Fairén, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea Carmine Belin, Andreas Puschmann, Clara Hellberg, Carl E Clarke, Karen Morrison, Manuela Tan, Dimitri Krainc, Lena F. Burbulla, Matthew J. Farrer, Rejko Krüger, Thomas Gasser, Manu Sharma, Alexis Elbaz
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 4
    Start Page: 857
    End Page: 864
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28902
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28902
    Citation Count: 32
  • What's New at the Journal in 2022
    2022
    Summary Details
    RESTRICTED
    Title: What's New at the Journal in 2022
    Author(s): A. Jon Stoessl
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 1
    Start Page: 1
    End Page: 2
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28906
    Citation Count: 0
  • c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities
    2022
    Summary Details
    RESTRICTED
    Title: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities
    Author(s): Kalpana Merchant, James F. Sullivan
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 1
    Start Page: 3
    End Page: 5
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28907
    Citation Count: 3
  • Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease
    2022
    Summary Details
    RESTRICTED
    Title: Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease
    Author(s): Iván Martínez-Valbuena, Naomi P. Visanji, Diana A. Olszewska, Mário Sousa, Puja Bhakta, Anna Vasilevskaya, Chloe Anastassiadis, Maria Carmela Tartaglia, Gábor G. Kovács, Anthony E. Lang
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 3
    Start Page: 648
    End Page: 650
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28912
    Citation Count: 29
  • Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale
    2022
    Summary Details
    RESTRICTED
    Title: Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale
    Author(s): Hanan Khalil, Zakiyah Aldaajani, Mayis Aldughmi, Alham Al‐Sharman, Tareq Mohammad Mohammad, Raja Mehanna, Shaimaa I El-Jaafary, Ahmed Dahshan, Mouna Ben Djebara, Walaa A. Kamel, Hanan Amer, Mohammed Farghal, Fatema Abdulla, Nouf Al‐Talai, Muneer Abu Snineh, Nouha Farhat, Fatima Jamali, Rawan K. Matar, Heba Samir Abdelraheem, Nesma Ghonimi, Mishal Abu Al‐Melh, Sonia Elbhrawy, Majid S. Alotaibi, Shaimaa A. Elaidy, Shahad A. Almuammar, Jasem Al–Hashel, Riadh Gouider, Hatem Samir, Chokri Mhiri, Matěj Škorvánek, Jeffrey Lin, Pablo Martínez‐Martín, Glenn T. Stebbins, Sheng Luo, Christopher G. Goetz, Jawad A. Bajwa
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 4
    Start Page: 826
    End Page: 841
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28905
    Citation Count: 6
  • Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity
    2022
    Summary Details
    RESTRICTED
    Title: Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity
    Author(s): Nurit Omer, Nir Giladi, Tanya Gurevich, Anat Bar‐Shira, Mali Gana‐Weisz, Tal Glinka, Orly Goldstein, Meir Kestenbaum, Jesse M. Cedarbaum, Omar S. Mabrouk, Kyle Fraser, Julia Shirvan, Avi Orr‐Urtreger, Anat Mirelman, Avner Thaler
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 37
    Issue #: 3
    Start Page: 651
    End Page: 652
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28929
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.